Back to top
more

QuidelOrtho (QDEL)

(Delayed Data from NSDQ)

$24.40 USD

24.40
1,722,894

+0.96 (4.10%)

Updated Aug 7, 2025 04:00 PM ET

After-Market: $24.42 +0.02 (0.08%) 7:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 37% (156 out of 246)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

PerkinElmer (PKI) Receives FDA EUA for Asymptomatic Testing

by Zacks Equity Research

PerkinElmer's (PKI) RT-PCR assay to test individuals without COVID-19 symptoms acts as prime factor in controlling the spread.

Nitish Marwah headshot

4 Momentum Stocks to Explore the Lucrative Driehaus Strategy

by Nitish Marwah

Investors who have the propensity to take a higher risk can think of investing in momentum stocks to boost their gains.

Zacks Equity Research

Quidel (QDEL) Gains As Market Dips: What You Should Know

by Zacks Equity Research

Quidel (QDEL) closed the most recent trading day at $198.03, moving +0.05% from the previous trading session.

Zacks Equity Research

3 Reasons Why Growth Investors Shouldn't Overlook Quidel (QDEL)

by Zacks Equity Research

Quidel (QDEL) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Zacks Equity Research

The Zacks Analyst Blog Highlights: Abbott Lab, QIAGEN, Quidel, Hologic and Quest Diagnostics

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Abbott Lab, QIAGEN, Quidel, Hologic and Quest Diagnostics

Zacks Equity Research

QDEL vs. RMD: Which Stock Is the Better Value Option?

by Zacks Equity Research

QDEL vs. RMD: Which Stock Is the Better Value Option?

Zacks Equity Research

Neogen (NEOG) Launches Dairy Toxin Detection Test Reveal Q+

by Zacks Equity Research

Neogen's (NEOG) new test can detect cancer causing aflatoxin M1 in milk within a range of 150-600 parts per trillion (ppt).

Urmimala Biswas headshot

Testing Space in Focus Again Thanks to New Wave of Coronavirus

by Urmimala Biswas

The resurgence in coronavirus infections is drawing attention back to the diagnostic testing space.

Zacks Equity Research

Baxter (BAX) Inks Sterile Manufacturing Agreement With Novavax

by Zacks Equity Research

Baxter's (BAX) BioPharma Solutions business inks deal to advance commercial-scale production and increase access for the COVID-19 vaccine in the U.K. and European markets.

Zacks Equity Research

Stryker (SYK) Buys OrthoSensor to Grow in Sensor Technology

by Zacks Equity Research

Stryker's (SYK) acquisition of OrthoSensor will help surgeons with real-time data-driven solutions and improve patient outcomes.

Kevin Cook headshot

Bull of the Day: Meridian Bioscience (VIVO)

by Kevin Cook

Small-cap diagnostics player will grow sales 20%+ to over $310 million on COVID-19 testing and its mutations

Zacks Equity Research

Encompass Health (EHC) Forms JV to Boost Presence in Illinois

by Zacks Equity Research

Encompass Health (EHC) forms JV with UnityPoint Health - Trinity for constructing an inpatient rehabilitation hospital in Illinois to provide better health services in the state.

Zacks Equity Research

Top Ranked Momentum Stocks to Buy for January 7th

by Zacks Equity Research

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, January 7th.

Zacks Equity Research

Is Quidel (QDEL) Outperforming Other Medical Stocks This Year?

by Zacks Equity Research

Is (QDEL) Outperforming Other Medical Stocks This Year?

Zacks Equity Research

Top Ranked Momentum Stocks to Buy for January 5th

by Zacks Equity Research

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, January 5th.

Zacks Equity Research

Allscripts (MDRX) Completes Sale of CarePort Health Business

by Zacks Equity Research

Allscripts' (MDRX) agreement with WellSky empowers providers with efficient care transitions and better patient health outcomes.

Nitish Marwah headshot

4 Top Momentum Stocks Powered by Driehaus Strategy

by Nitish Marwah

Investors with a high-risk appetite might give the Driehaus strategy a thought to boost their returns.

Zacks Equity Research

Maximize Your Portfolio Returns With Momentum Anomaly Stocks

by Zacks Equity Research

Shopify (SHOP), Trade Desk (TTD), Williams-Sonoma (WSM) and Quidel (QDEL) are currently witnessing a short-term pullback in price. So make sure you're taking full advantage of it.

Zacks Equity Research

Medtronic (MDT) MITG Shows Fast Recovery Amid COVID-19 Woes

by Zacks Equity Research

Medtronic (MDT) expects fiscal third-quarter MITG growth to be in the low single digits.

Zacks Equity Research

Quidel (QDEL) Stock Sinks As Market Gains: What You Should Know

by Zacks Equity Research

Quidel (QDEL) closed at $197.49 in the latest trading session, marking a -1.26% move from the prior day.

Zacks Equity Research

Here's Why Hold Strategy is Apt for Magellan (MGLN) Stock

by Zacks Equity Research

Magellan Health (MGLN) has been benefiting from persistent tie-ups for offering enhanced behavioral health solutions and prudent capital deployment measures.

Urmimala Biswas headshot

4 MedTech Stocks Up More Than 100% in 2020 With Room to Run

by Urmimala Biswas

We discuss four MedTech stocks, CDNA, FLGT, OMI and QDEL that more than doubled in 2020, and are poised to maintain market beating momentum in 2021 on strong fundamentals.

Zacks Equity Research

Ensign Group (ENSG) Rewards Shareholders With Dividend Hike

by Zacks Equity Research

Ensign Group's (ENSG) latest dividend hike indicates strong financial standing and continuous focus on boosting shareholders' value.

Zacks Equity Research

The Zacks Analyst Blog Highlights: Quidel, Halozyme Therapeutics, Teladoc Health, Acceleron Pharma and BioCryst Pharmaceuticals

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Quidel, Halozyme Therapeutics, Teladoc Health, Acceleron Pharma and BioCryst Pharmaceuticals

Srijita Guha headshot

4 Healthcare Stocks to Take Care of in 2021 to Boost Portfolio

by Srijita Guha

Based on strong fundamentals, here we talk about four healthcare stocks to keep in your watchlist for 2021.